Kevin Koch Edgewise Therapeutics, Inc. (EWTX) insider trading activity
Kevin Koch is President and CEO of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 14,478 shares of EWTX, which is worth approximately $434,050. The most recent transaction as insider was on May 02, 2024, when has been sold 3,152 shares (Common Stock) at a price of $18.91 per share, resulting in proceeds of $59,604. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
14.5K
0%
3M change
100.72%
12M change
Total Value Held
$434,050
KEVIN KOCH Transaction History
KK
Kevin Koch
President and CEO
Boulder, CO